Key Contribution This study demonstrates that GLP-1 receptor agonist therapy is associated with reduced risks of urinary retention and urinary tract infection in non-diabetic adults receiving BTX-A for overactive bladder, independent of weight loss
Additionally, focusing on protein intake and fiber helps prolong satiety between meals, amplifying the semaglutide effect even at a lower dose
The level of stress-related pathology varies from one person to another, due to the differences in the levels of immune and inflammatory response specifically mast cell response to various stressors and activation signals (Forsythe and Ennis, 2000
The 21-28 day recommendation accounts for this additional degradation pathway
Electrocardiography (ECG) Simultaneously with echocardiography, electrocardiography measurements were performed before the treatment, and on the seventh and fourteenth day
Real-world Data and Treatment Guidelines One of the strengths of this study was its use of real-world data, providing valuable insights into the effectiveness of semaglutide outside of controlled clinical trials
